1,473
Participants
Start Date
December 31, 2006
Primary Completion Date
March 31, 2019
Study Completion Date
December 31, 2020
Dalteparin
5,000 iu or 200 iu/kg depending on the type of surgery injection will be given subcutaneously, once a day for a minimum of 4 days or until the INR is 2.0
Placebo
"patients will be randomized post-operative to receive either active treatment or placebo.~the placebo will be given as a subcutaneous injection once a day. the amount of the placebo will be equivalent to the active treatment depending on the type of surgery.~ie. 5,000 iu or 200 iu/kg"
Sir Ganga Ram Hospital, New Delhi
Care Hospital, Hyderabad
QE II Health Sciences Centre, Halifax
Hamilton Health Sciences Corporation-General Hospital, Hamilton
Hamilton Health Sciences Corporation-McMaster Site, Hamilton
Hamilton Health Sciences Corporation-Henderson Site, Hamilton
Ottawa Hospital-General Campus, Ottawa
SMBD Jewish General Hospital, Montreal
Collaborators (1)
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Pfizer
INDUSTRY
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
OTHER